<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00919620</url>
  </required_header>
  <id_info>
    <org_study_id>jcep-rct</org_study_id>
    <nct_id>NCT00919620</nct_id>
  </id_info>
  <brief_title>Stage-specific Case Management for Early Psychosis</brief_title>
  <official_title>Outcome of Stage-specific Early Intervention for Psychosis in Hong Kong: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Queen Mary Hospital, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kwai Chung Hospital, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kowloon Hospital, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Castle Peak Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shatin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tai Po Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>North District Hospital, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queen Elizabeth Hospital, Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the commonly adopted strategies in improving outcome in psychotic disorders is by&#xD;
      focused, specific and intensive intervention in the initial few years of the disorder.&#xD;
      However the effects of intervention and the optimal duration of intervention have seldom been&#xD;
      examined in randomized studies. This study uses a randomized controlled study design to&#xD;
      investigate the effectiveness of stage-specific case-management in improving outcome of first&#xD;
      episode psychotic disorders. It also addresses whether two years of case-management is less&#xD;
      effective than four years of case-management over a four year period. A total of 360&#xD;
      subjects, who aged 25 above, and diagnosed with first episode psychotic disorders, will be&#xD;
      and randomized into 3 groups: (1) standard care alone without case management, (2) two-year&#xD;
      case management, (3) four-year case management. All groups will receive usual standard care&#xD;
      treatment. This four-year follow-up study will assess symptoms, functioning, quality of life&#xD;
      as well as health economics data.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Psychotic disorder is a debilitating illness which imposes substantial impact to the&#xD;
      patients, their families, and the society. The provision of early intervention provides a&#xD;
      window of opportunity to minimize the social and economic burden incurred by the illness.&#xD;
&#xD;
      Many previous studies of effectiveness of early intervention used the historical control&#xD;
      approach and are subjected to cohort effects. For example, change of medication pattern over&#xD;
      time could potentially lead to differences in outcome. In addition, few studies provide&#xD;
      longer-term outcome data of treatment program beyond two years. The optimal length of&#xD;
      intervention has not been determined, and many programmes used 12-24 month intervention&#xD;
      mainly based on resources available. It is also important to ask whether favorable effects of&#xD;
      early intervention could be sustained over time. Further analyses will be done to assess&#xD;
      whether EI effects are more pronounced in particular subgroups including DUP, age, sex and&#xD;
      diagnosis.&#xD;
&#xD;
      The proposed study aims to address these issues by using a randomized controlled design to&#xD;
      investigate the longer-term (4 year) outcome of patients with first episode psychosis. The&#xD;
      study randomizes 360 patients with first episode psychotic disorders into 3 groups: (1)&#xD;
      standard care (outpatient based care with inpatient and community care as required); (2)&#xD;
      standard care with 2 years of add-on stage specific case-management (individualized care&#xD;
      delivered by designated case managers according to specific protocol); and (3) standard care&#xD;
      with 4 years of add-on stage specific case management.&#xD;
&#xD;
      The study hypothesis are: (1) both 2 years and 4 years of case management produce better&#xD;
      outcomes than standard care alone; (2) 4 years of case management produces better outcome&#xD;
      than 2 years of case management.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functioning (social and occupational)</measure>
    <time_frame>baseline, 6-month, 12-month, 24-month, 36-month, 48-month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychotic symptoms</measure>
    <time_frame>baseline, 6-month, 12-month, 24-month, 36-month, 48-month</time_frame>
    <description>Psychotic symptoms will be assessed using the Positive and Negative Syndrome Scale (PANSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychotic symptoms</measure>
    <time_frame>baseline, 6-month, 12-month, 24-month, 36-month, 48-month</time_frame>
    <description>Psychotic symptoms will be assessed using Scale for the Assessment of Positive Symptoms (SAPS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychotic symptoms</measure>
    <time_frame>baseline, 6-month, 12-month, 24-month, 36-month, 48-month</time_frame>
    <description>Psychotic symptoms will be assessed using Scale for the Assessment of Negative Symptoms (SANS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms</measure>
    <time_frame>baseline, 12-month, 24-month, 36-month, 48-month</time_frame>
    <description>Depressive symptoms will be assessed using the Calgary Depression Scale for Schizophrenia (CDSS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive functioning</measure>
    <time_frame>baseline, 12-month, 24-month, 36-month, 48-month</time_frame>
    <description>A battery of neurocognitive tests will be conducted, including Handedness, Trail Making, Wisconsin Card Sorting Test, Semantic Verbal Fluency, Logical Verbal Memory, Visual Patterns Test, Letter Number Span, Monotone Counting, and Soft Neurological Signs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economics</measure>
    <time_frame>baseline, 6-month, 12-month, 24-month, 36-month, 48-month</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Psychotic Disorders</condition>
  <arm_group>
    <arm_group_label>case management (4 yrs)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4-year case management and standard care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>case management (2 yrs) and standard care (2 yrs)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2-year case management and standard care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care (4 yrs)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard care for 4 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>stage-specific case-management</intervention_name>
    <description>Stage-specific case-management for psychosis by designated key-workers according to specified protocol</description>
    <arm_group_label>case management (2 yrs) and standard care (2 yrs)</arm_group_label>
    <arm_group_label>case management (4 yrs)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  DSM-IV diagnosis of schizophrenia, schizoaffective disorder, schizophreniform&#xD;
             psychosis, brief psychosis, psychosis nos or delusional disorder&#xD;
&#xD;
          -  Cantonese-speaking Chinese&#xD;
&#xD;
          -  Ability to understand the nature of the study and sign informed consent&#xD;
&#xD;
          -  Capacity to participate in cognitive testing&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Organic Brain disorder&#xD;
&#xD;
          -  Known history of intellectual disability&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>26 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric YH Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 10, 2009</study_first_submitted>
  <study_first_submitted_qc>June 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2009</study_first_posted>
  <last_update_submitted>November 10, 2020</last_update_submitted>
  <last_update_submitted_qc>November 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Professor Eric Y.H. Chen</investigator_full_name>
    <investigator_title>Professor and Head of Department of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>Psychotic disorders</keyword>
  <keyword>Psychoses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

